Europe - Euronext Paris - EPA:IPN - FR0010259150 - Common Stock
Overall IPN gets a fundamental rating of 6 out of 10. We evaluated IPN against 55 industry peers in the Pharmaceuticals industry. IPN is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. IPN is not valued too expensively and it also shows a decent growth rate.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.56% | ||
| ROE | 10.59% | ||
| ROIC | 14.89% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.02% | ||
| PM (TTM) | 11.92% | ||
| GM | 83.32% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.2 | ||
| Debt/FCF | 1.46 | ||
| Altman-Z | 4.77 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.98 | ||
| Quick Ratio | 1.8 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.3 | ||
| Fwd PE | 11.98 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.25 | ||
| EV/EBITDA | 6.49 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.03% |
ChartMill assigns a fundamental rating of 6 / 10 to IPN.PA.
ChartMill assigns a valuation rating of 6 / 10 to IPSEN (IPN.PA). This can be considered as Fairly Valued.
IPSEN (IPN.PA) has a profitability rating of 6 / 10.
The financial health rating of IPSEN (IPN.PA) is 7 / 10.
The dividend rating of IPSEN (IPN.PA) is 4 / 10 and the dividend payout ratio is 25.94%.